高血压患者-话题@MedSci

#高血压患者#

283篇内容 | 4519人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1448380, encodeId=a995144838036, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=最强降压药美阿沙坦在我国重磅上市！高血压患者福音, objectType=article, longId=739739, objectId=47b0e3973921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47b0e3973921, replyNumber=0, likeNumber=113, createdTime=2022-09-18, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47b0e3973921, moduleTitle=最强降压药美阿沙坦在我国重磅上市！高血压患者福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47b0e3973921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448379, encodeId=8f3314483e9ff, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=领U盘：血压、MAU 双达标，全面心肾保护——安博维对高血压患者的临床获益, objectType=article, longId=739733, objectId=4a4de3973319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a4de3973319, replyNumber=0, likeNumber=141, createdTime=2022-09-18, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a4de3973319, moduleTitle=领U盘：血压、MAU 双达标，全面心肾保护——安博维对高血压患者的临床获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a4de3973319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448378, encodeId=d32b14483e820, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=中国学者：ARB降压药或可降低房颤合并高血压患者死亡率, objectType=article, longId=739398, objectId=5bc1e3939868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bc1e3939868, replyNumber=0, likeNumber=91, createdTime=2022-09-17, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bc1e3939868, moduleTitle=中国学者：ARB降压药或可降低房颤合并高血压患者死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bc1e3939868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448377, encodeId=1d9014483e7b1, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=JAHA：轮班工作与高血压患者的心脏代谢性多发病风险, objectType=article, longId=737664, objectId=3d2ce3766467, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d2ce3766467, replyNumber=0, likeNumber=107, createdTime=2022-09-04, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d2ce3766467, moduleTitle=JAHA：轮班工作与高血压患者的心脏代谢性多发病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d2ce3766467)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448376, encodeId=a99b14483e61b, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=一张处方单——长效守护高血压患者生命健康安博维/安博诺, objectType=article, longId=736888, objectId=18aae368882f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18aae368882f, replyNumber=0, likeNumber=119, createdTime=2022-08-26, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18aae368882f, moduleTitle=一张处方单——长效守护高血压患者生命健康安博维/安博诺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18aae368882f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448375, encodeId=b99214483e588, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=百万数据证实：初始用药高血压患者，ARB药物呈现出更好的安全性！, objectType=article, longId=736868, objectId=63eae36868ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63eae36868ce, replyNumber=0, likeNumber=142, createdTime=2022-08-26, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63eae36868ce, moduleTitle=百万数据证实：初始用药高血压患者，ARB药物呈现出更好的安全性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63eae36868ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448374, encodeId=acef14483e406, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=新一代ARB类降压药美阿沙坦钾，加强高血压患者的达标管理, objectType=article, longId=736524, objectId=ab86e3652455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab86e3652455, replyNumber=0, likeNumber=137, createdTime=2022-08-23, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab86e3652455, moduleTitle=新一代ARB类降压药美阿沙坦钾，加强高血压患者的达标管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab86e3652455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448372, encodeId=b57d14483e22f, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=tDCS+有氧运动，可有效降低高血压患者血压, objectType=article, longId=735870, objectId=1218e3587048, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1218e3587048, replyNumber=0, likeNumber=144, createdTime=2022-08-16, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1218e3587048, moduleTitle=tDCS+有氧运动，可有效降低高血压患者血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1218e3587048)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448371, encodeId=8c2d14483e181, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=厄贝沙坦 VS 厄贝沙坦氢氯噻嗪，高血压患者该如何选？, objectType=article, longId=735573, objectId=8999e35573db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8999e35573db, replyNumber=0, likeNumber=134, createdTime=2022-08-12, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8999e35573db, moduleTitle=厄贝沙坦 VS 厄贝沙坦氢氯噻嗪，高血压患者该如何选？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8999e35573db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448370, encodeId=6d6114483e0ff, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性, objectType=article, longId=735302, objectId=896ce35302c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896ce35302c5, replyNumber=0, likeNumber=122, createdTime=2022-08-10, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896ce35302c5, moduleTitle=Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896ce35302c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448369, encodeId=76641448369a3, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=Hypertension：RAAS抑制剂可显著降低高血压患者脑动脉瘤的破裂风险, objectType=article, longId=731842, objectId=7c41e31842d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c41e31842d7, replyNumber=0, likeNumber=81, createdTime=2022-07-10, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c41e31842d7, moduleTitle=Hypertension：RAAS抑制剂可显著降低高血压患者脑动脉瘤的破裂风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c41e31842d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448368, encodeId=7f5e1448368f5, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=Stroke：中国成人血清左旋肉碱水平与高血压患者首次卒中相关, objectType=article, longId=731390, objectId=841ae313906e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=841ae313906e, replyNumber=0, likeNumber=139, createdTime=2022-07-07, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=841ae313906e, moduleTitle=Stroke：中国成人血清左旋肉碱水平与高血压患者首次卒中相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=841ae313906e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448367, encodeId=102c144836efd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=老年高血压患者，应该如何管理？, objectType=article, longId=731054, objectId=91a3e3105465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91a3e3105465, replyNumber=0, likeNumber=117, createdTime=2022-07-03, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91a3e3105465, moduleTitle=老年高血压患者，应该如何管理？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91a3e3105465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448366, encodeId=ffaf144836694, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=Lancet：肾去神经治疗可作为高血压患者的辅助治疗手段，其效果独立于降压药！, objectType=article, longId=730342, objectId=a42ce30342e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a42ce30342e7, replyNumber=0, likeNumber=94, createdTime=2022-06-25, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a42ce30342e7, moduleTitle=Lancet：肾去神经治疗可作为高血压患者的辅助治疗手段，其效果独立于降压药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a42ce30342e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448365, encodeId=37601448365bb, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=J Nurs Sch：促进高血压患者健康生活方式和血压控制的网络护理计划, objectType=article, longId=730070, objectId=f34be300703d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f34be300703d, replyNumber=0, likeNumber=164, createdTime=2022-06-22, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f34be300703d, moduleTitle=J Nurs Sch：促进高血压患者健康生活方式和血压控制的网络护理计划, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f34be300703d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448363, encodeId=9b9a1448363ea, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=OCC 2022 | 基层难治性高血压患者管理, objectType=article, longId=727956, objectId=32b3e2795646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b3e2795646, replyNumber=0, likeNumber=95, createdTime=2022-05-28, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b3e2795646, moduleTitle=OCC 2022 | 基层难治性高血压患者管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b3e2795646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448362, encodeId=cacb14483624d, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=【40元京豆梅斯有奖问卷】高血压患者院外管理的现状有偿调研, objectType=article, longId=727434, objectId=7925e27434cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7925e27434cf, replyNumber=0, likeNumber=103, createdTime=2022-05-22, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7925e27434cf, moduleTitle=【40元京豆梅斯有奖问卷】高血压患者院外管理的现状有偿调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7925e27434cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448360, encodeId=bd2a144836070, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=高血压患者如何用药？最新指南这样说 | 世界高血压日, objectType=article, longId=727207, objectId=3d48e27207b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d48e27207b6, replyNumber=0, likeNumber=111, createdTime=2022-05-19, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d48e27207b6, moduleTitle=高血压患者如何用药？最新指南这样说 | 世界高血压日, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d48e27207b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448359, encodeId=8b5a14483594a, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=JAHA：早期高血压患者组织中钠含量的临床意义, objectType=article, longId=724553, objectId=aeffe24553c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aeffe24553c7, replyNumber=0, likeNumber=121, createdTime=2022-04-20, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aeffe24553c7, moduleTitle=JAHA：早期高血压患者组织中钠含量的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aeffe24553c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448358, encodeId=8f8c1448358e1, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, objectTitle=Hypertension：直立性高血压，或许预示年轻高血压患者不良后果, objectType=article, longId=301784, objectId=8e72301e8413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e72301e8413, replyNumber=0, likeNumber=112, createdTime=2022-03-29, rootId=0, userName=维他命, userId=b4665409655, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e72301e8413, moduleTitle=Hypertension：直立性高血压，或许预示年轻高血压患者不良后果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e72301e8413)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高血压患者

2020-05-29

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

最强降压药美阿沙坦在我国重磅上市！高血压患者福音

2022-09-18

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

领U盘：血压、MAU 双达标，全面心肾保护——安博维对高血压患者的临床获益

2022-09-18

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

中国学者：ARB降压药或可降低房颤合并高血压患者死亡率

2022-09-17

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

JAHA：轮班工作与高血压患者的心脏代谢性多发病风险

2022-09-04

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

一张处方单——长效守护高血压患者生命健康安博维/安博诺

2022-08-26

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

百万数据证实：初始用药高血压患者，ARB药物呈现出更好的安全性！

2022-08-26

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

新一代ARB类降压药美阿沙坦钾，加强高血压患者的达标管理

2022-08-23

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

tDCS+有氧运动，可有效降低高血压患者血压

2022-08-16

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

厄贝沙坦 VS 厄贝沙坦氢氯噻嗪，高血压患者该如何选？

2022-08-12

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

Cardiovasc Diabetol：TyG指数变化轨迹与高血压患者卒中风险的相关性

2022-08-10

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

Hypertension：RAAS抑制剂可显著降低高血压患者脑动脉瘤的破裂风险

2022-07-10

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

Stroke：中国成人血清左旋肉碱水平与高血压患者首次卒中相关

2022-07-07

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

老年高血压患者，应该如何管理？

2022-07-03

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

Lancet：肾去神经治疗可作为高血压患者的辅助治疗手段，其效果独立于降压药！

2022-06-25

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

J Nurs Sch：促进高血压患者健康生活方式和血压控制的网络护理计划

2022-06-22

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

OCC 2022 | 基层难治性高血压患者管理

2022-05-28

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

【40元京豆梅斯有奖问卷】高血压患者院外管理的现状有偿调研

2022-05-22

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

高血压患者如何用药？最新指南这样说 | 世界高血压日

2022-05-19

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

JAHA：早期高血压患者组织中钠含量的临床意义

2022-04-20

维他命 (审核中...)

前往app查看评论内容

#高血压患者#

Hypertension：直立性高血压，或许预示年轻高血压患者不良后果

2022-03-29

科室
- - 订阅+
  - 更多科室
工具
服务